Literature DB >> 19070839

Survival of trauma patients with coma and bilateral fixed dilated pupils.

Krishanu Chaudhuri1, Gregory M Malham, Jeffrey V Rosenfeld.   

Abstract

BACKGROUND: Survival of patients with severe trauma presenting with Glasgow Coma Score (GCS) 3 and bilateral fixed dilated pupils is uncertain. Pre-hospital management of these patients affects the true measurement of the GCS and other factors may affect pupillary status. PATIENTS AND METHODS: A retrospective review was undertaken of all patients who were classified GCS 3 and had bilateral fixed dilated pupils on admission to a Level 1 Adult Trauma Centre between July 2001 and March 2005. Pre-hospital assessment, hospital interventions and outcomes were determined.
RESULTS: Ninety-three patients fulfilled the criteria for inclusion into the study. There were 6 survivors who were all less than 28 years of age, had at least one GCS score above 3 in the pre-hospital phase and were more likely to have had an evacuable mass lesion on CT brain scan and undergo craniotomy. Of the 6 surviving patients, none had significant thoracoabdominal injuries. Four of the survivors had Glasgow Outcome Score (GOS) of 4 or 5. Time to hospital, mechanism of injury and pre-hospital haemodynamic parameters had no significant effect on survival. Of the 57 patients who were GCS 3 at the scene of the accident, post-basic resuscitation and on admission, none survived.
CONCLUSION: Pre-hospital GCS scores, prior to the effects of intubation, sedation and paralysis should be given more attention when assessing prognosis in patients who are GCS 3 on admission. Trauma patients with GCS 3 persisting from the scene with bilaterally fixed dilated pupils have no appreciable chance of survival. Further interventions such as ICU admission and surgery may not be warranted. Physicians may need to consider stopping treatment and discussing organ donation.

Entities:  

Mesh:

Year:  2008        PMID: 19070839     DOI: 10.1016/j.injury.2008.09.004

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  8 in total

1.  Emergent Decompressive Craniectomy in Patients with Fixed DilatedPupils; A Single Center Experience.

Authors:  Luis Rafael Moscote-Salazar; Hernando Raphael Alvis-Miranda; Camilo Palencia; Andres M Rubiano
Journal:  Bull Emerg Trauma       Date:  2013-10

Review 2.  Baseline Predictors of Survival, Neurological Recovery, Cognitive Function, Neuropsychiatric Outcomes, and Return to Work in Patients after a Severe Traumatic Brain Injury: an Updated Review.

Authors:  Haifa Algethamy
Journal:  Mater Sociomed       Date:  2020-06

3.  The prognostic reliability of the Glasgow coma score in traumatic brain injuries: evaluation of MRI data.

Authors:  D Woischneck; R Firsching; B Schmitz; T Kapapa
Journal:  Eur J Trauma Emerg Surg       Date:  2012-12-28       Impact factor: 3.693

4.  Surgical decision making for the elderly patients in severe head injuries.

Authors:  Kyeong-Seok Lee; Jae-Jun Shim; Seok-Man Yoon; Jae-Sang Oh; Hack-Gun Bae; Jae-Won Doh
Journal:  J Korean Neurosurg Soc       Date:  2014-04-30

5.  Predictive Factors of Survival and 6-Month Favorable Outcome of Very Severe Head Trauma Patients; a Historical Cohort Study.

Authors:  Karin Vathanalaoha; Thakul Oearsakul; Thara Tunthanathip
Journal:  Emerg (Tehran)       Date:  2017-01-10

6.  Clinical Nomogram Predicting Intracranial Injury in Pediatric Traumatic Brain Injury.

Authors:  Thara Tunthanathip; Jarunee Duangsuwan; Niwan Wattanakitrungroj; Sasiporn Tongman; Nakornchai Phuenpathom
Journal:  J Pediatr Neurosci       Date:  2021-01-19

7.  The Expanding Role of Quantitative Pupillometry in the Evaluation and Management of Traumatic Brain Injury.

Authors:  Jason H Boulter; Margaret M Shields; Melissa R Meister; Gregory Murtha; Brian P Curry; Bradley A Dengler
Journal:  Front Neurol       Date:  2021-07-12       Impact factor: 4.003

8.  Lasting bilateral mydriasis after traumatic brain injury may not always be a lost case.

Authors:  Alkinoos Athanasiou; Ioannis Balogiannis; Ioannis Magras
Journal:  Surg Neurol Int       Date:  2017-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.